Results 41 to 50 of about 112,416,099 (307)

Herpes simplex virus interference with immunity: Focus on dendritic cells

open access: yesVirulence, 2021
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are highly prevalent in the human population. These viruses cause lifelong infections by establishing latency in neurons and undergo sporadic reactivations that promote recurrent disease and new ...
Farías MA   +3 more
doaj   +1 more source

Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2

open access: yesViruses, 2023
(1) Background: Epigallocatechin gallate (EGCG) has been recognized as a flavonoid showing antiviral activity against various types of DNA and RNA viruses.
Malgorzata Krzyzowska   +8 more
doaj   +1 more source

De Novo synthesis of VP16 coordinates the exit from HSV latency in vivo [PDF]

open access: yes, 2009
The mechanism controlling the exit from herpes simplex virus latency (HSV) is of central importance to recurrent disease and transmission of infection, yet interactions between host and viral functions that govern this process remain unclear. The cascade
Sawtell, N.M.   +5 more
core   +1 more source

Vaginal HSV-2 Infection and Tissue Analysis [PDF]

open access: yesBIO-PROTOCOL, 2017
The vaginal murine HSV-2 infection model is very useful in studying mucosal immunity against HSV-2 ( Overall et al., 1975 ; Renis et al., 1976 ; Parr and Parr, 2003). Histologically, the vagina of Depo-Provera-treated mice is lined by a single layer of mucus secreting columnar epithelial cells overlying two to three layers of proliferative cells.
Marie Iversen   +2 more
openaire   +3 more sources

HSV-2 Induced Cerebellitis: A Case Report of HSV-2 Reactivation by SARS-CoV-2 Infection

open access: yesThe Open Neurology Journal, 2023
Background: Herpes simplex virus type 2 rarely causes encephalitis in humans. Some DNA viruses, such as HSV-1 and HSV-2, can be reactivated by COVID-19 infection. SARS-CoV-2 causes a wide spectrum of neurological deficits, such as stroke, delirium, movement disorders, and neuropathy. Case Presentation: An
Fahimeh Ehsanipur   +3 more
openaire   +1 more source

Anti-herpes simplex virus (HSV)-1 and anti-HSV-2 activities of monogalactosyl diacylglyceride (MGDG).

open access: yes, 2019
Anti-herpes simplex virus (HSV)-1 and anti-HSV-2 activities of monogalactosyl diacylglyceride (MGDG).
Jung-Bum Lee (707906)   +7 more
core   +1 more source

Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons

open access: yesViruses, 2021
Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) can infect the central nervous system (CNS) with dire consequences; in children and adults, HSV-1 may cause focal encephalitis, while HSV-2 causes meningitis.
Petra Bergström   +13 more
doaj   +1 more source

HSV-2 shedding before and after immunisation.

open access: yes, 2019
HSV-2 shedding rates were assessed over 45-day swabbing periods before immunisation, after immunisation and after booster immunisation. (A) The number of days with HSV-2 detected was normalized per year. Shown are mean values with 95% CI.
Julie L. Dutton (8138424)   +11 more
core   +1 more source

Incidence and risk factors for herpes simplex virus type 2 seroconversion among pregnant women in Uganda: A prospective study

open access: yesJournal of Infection in Developing Countries, 2016
Introduction: Herpes simplex virus type 2 (HSV-2) acquired during pregnancy is associated with adverse outcomes such as perinatal HSV-2 transmission. HSV-2 seroconversion occurs within four weeks of HSV-2 acquisition.
Sarah Nakubulwa   +5 more
doaj   +1 more source

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. [PDF]

open access: yesPLoS ONE, 2017
BACKGROUND:In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX® B/E boost reduced HIV-1 acquisition by 31% at 42 months post first vaccination.
Peter B Gilbert   +24 more
doaj   +1 more source

Home - About - Disclaimer - Privacy